Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis
PolandStudy on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors
PolandStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
PolandStudy on the Effectiveness and Safety of Riliprubart Compared to Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
PolandStudy on Nipocalimab for Adults with Generalized Myasthenia Gravis
PolandStudy on BI 764532 for Patients with Relapsed or Refractory Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
PolandStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
PolandStudy on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia
PolandStudy on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus
PolandStudy on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus
PolandStudy on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma
PolandStudy on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
